Effective 1 de octubre de 2021, the Transurethral Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia policy is being updated to include Transurethral Water Jet Ablation (Aquablation) service. This added service will require authorization for Medicare Advantage plans and will not be medically necessary for commercial products. HCPCS C2596 code will change from covered to not medically necessary for commercial products. There will be no changes for Medicare Advantage plans related to HCPCS C2596. Please click here for additional details.